Paradigm Biopharmaceuticals
Melbourne, Victoria, Australia · Biotechnology, Health Care, Therapeutics
Paradigm Biopharmaceuticals is a Melbourne-based biotechnology company focused on innovative treatments for patients with osteoarthritis. They are currently advancing their Phase 3 clinical trial and preparing for regulatory submissions. The company aims to improve the quality of life for individuals affected by joint diseases.
Key facts
- Headquarters
- Melbourne, Victoria, Australia
- Employees
- 25
- Industries
- Biotechnology, Health Care, Therapeutics
- Status
- Private
- Website
- paradigmbiopharma.com
- Company page
Recent activity at Paradigm Biopharmaceuticals
Leadership
- Dr Daniel Furtner, Chief Medical Officer
Verified email and direct lines for Paradigm Biopharmaceuticals’s decision-makers are on Fundz. See plans
Paradigm Biopharmaceuticals in the news
- Paradigm Biopharma (ASX:PAR) Shares Jump on Monday – Here’s Why - Kalkine (Jun 15, 2026)
- Paradigm Biopharmaceuticals Limited (PAR.AX) stock price, news, quote and history - Yahoo Finance Australia (May 29, 2017)
- Paradigm Biopharmaceuticals Appoints Marco Polizzi as CEO - citybiz (Jun 27, 2022)
- Pentosan Polysulfate Sodium SC Injection Fast Tracked for Osteoarthritis - Medical Professionals Reference (Apr 13, 2022)
- Paradigm Biopharma’s knee osteoarthritis trial meets secondary endpoints, launches capital raise - smallcaps.com.au (Oct 30, 2022)
- Paradigm Biopharmaceuticals Limited (PAR.XA) company profile and facts - Yahoo Finance Australia (Nov 09, 2021)
- Paradigm Biopharmaceuticals Limited (ASX:PAR) - intelligentinvestor.com.au (Sep 24, 2019)
- Paradigm Biopharma receives FDA clearance for investigational new osteoarthritis drug - smallcaps.com.au (Sep 10, 2019)
Companies similar to Paradigm Biopharmaceuticals
- Tenpoint Therapeutics · Biotechnology, Health Care, Therapeutics
- Navigator Medicines · Biotechnology, Health Care, Therapeutics
- Gradalis · Biotechnology, Health Care, Therapeutics
- Anavo Therapeutics · Biotechnology, Health Care, Therapeutics
- Aethlon Medical · Biotechnology, Health Care, Therapeutics
About Paradigm Biopharmaceuticals: questions and answers
What does Paradigm Biopharmaceuticals do?
Paradigm Biopharmaceuticals is a Melbourne-based biotechnology company focused on innovative treatments for patients with osteoarthritis. They are currently advancing their Phase 3 clinical trial and preparing for regulatory submissions. The company aims to improve the quality of life for individuals affected by joint diseases.
Where is Paradigm Biopharmaceuticals headquartered?
Paradigm Biopharmaceuticals is headquartered in Melbourne, Victoria, Australia.
How many employees does Paradigm Biopharmaceuticals have?
Paradigm Biopharmaceuticals has about 25 employees.
What is the latest news on Paradigm Biopharmaceuticals?
On Sep 17, 2026, Paradigm Biopharmaceuticals Appoints Dr Daniel Furtner as Chief Medical Officer
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy